CAPITAL CITY BANK GROUP INC quarterly report, Q3 FY2013

Capital City Bank Group, Inc. — Q3 2013 Form 10-Q

Business context and reporting period

Unaudited results for the quarter and nine months ended September 30, 2013. Capital City Bank Group is a Florida bank holding company operating 63 full-service offices in Florida, Georgia and Alabama, with commercial and retail banking, wealth management, brokerage and data processing services.

Financial performance and condition

  • Q3 earnings: Net income was $1.6 million, or $0.09 per diluted share, versus $1.1 million, or $0.07, in Q3 2012. Nine-month net income was $3.3 million, compared with a $1.8 million loss in the first nine months of 2012.
  • Revenue and margins: Q3 net interest income was $19.2 million ($19.4 million tax-equivalent); noninterest income was $14.3 million. Tax-equivalent net interest margin was 3.49%, down from 3.82% a year earlier. Nine-month tax-equivalent net interest income declined to $59.2 million from $64.2 million.
  • Costs and credit: Q3 provision for loan losses was $0.6 million versus $2.9 million a year earlier. Nine-month provision fell to $3.1 million from $13.4 million. Noninterest expense was $30.4 million in Q3 and $92.2 million year to date, down 3.0% year over year for the nine-month period. Q3 efficiency ratio was 90.42%.
  • Asset quality: Nonperforming assets were $94.7 million, or 3.77% of assets, down $22.9 million from year-end 2012. Nonaccrual loans were $41.7 million and other real estate owned (OREO) was $53.0 million. Net charge-offs were $2.8 million in Q3 (0.78% annualized) and $7.2 million for the first nine months. The $25.0 million allowance equaled 1.75% of loans and covered 60% of nonperforming loans.
  • Balance sheet and liquidity: Total assets were $2.514 billion, down from $2.634 billion at December 31, 2012. Loans, net of unearned income, were $1.418 billion, versus $1.507 billion at year-end; deposits were $2.017 billion, versus $2.145 billion. Cash and equivalents were $410.0 million, down $99.7 million since year-end. Management reported $762.2 million of additional available liquidity.
  • Cash flow and debt: Nine-month operating cash flow was $30.0 million; investing activities used $0.3 million and financing activities used $129.4 million, including a $128.1 million net deposit decrease. Period-end borrowings included $51.9 million short-term, $62.9 million subordinated notes and $40.2 million other long-term borrowings.
  • Capital: Shareowners’ equity was $251.2 million. The risk-based total capital ratio was 16.97%, leverage ratio 10.16%, and tangible capital ratio 6.84%. Management described the Bank as well-capitalized.

Material changes and management commentary

  • Year-to-date earnings improved from a loss to profit chiefly because loan-loss provisions and OREO-related costs declined. Total credit costs were $10.5 million for the first nine months, versus $22.9 million in 2012.
  • Credit quality improved overall: criticized loans declined to $200.5 million from $250.9 million at year-end 2012, while nonperforming assets also fell. However, Q3 net charge-offs rose from Q2, and allowance coverage of nonperforming loans fell from 66% at June 30 to 60%.
  • Loan balances continued to contract, reflecting amortization, payoffs exceeding new production, weak demand and problem-loan resolution. Management said new production had improved over recent quarters and described lending initiatives, while stating it would not compromise credit standards.
  • Management expects continued net interest margin pressure through at least the remainder of 2013 and into 2014, citing low rates, loan declines, asset repricing and competition. It reported no numeric earnings guidance.
  • The company transferred securities with approximately $63.0 million fair value from available-for-sale to held-to-maturity and purchased $39.1 million of held-to-maturity securities during Q3. It recorded $0.4 million of impairment on a bank preferred-stock investment year to date; goodwill testing found no impairment.

Outlook, risks and contingencies

  • Management anticipated seasonal public-fund deposit inflows late in Q4 and into Q1 2014, and said it may deploy some overnight funds into securities. It expected approximately $3.0 million of capital expenditures over the next 12 months.
  • Key stated risks include interest-rate and liquidity risk, continued loan contraction and credit losses, real-estate exposure and geographic/industry concentrations, economic weakness in its markets, regulatory constraints, competition, and the possibility of goodwill or loan-loss estimate changes.
  • The company had $283.8 million of commitments to extend credit and $11.3 million of standby letters of credit. Management said many commitments may expire undrawn and did not anticipate material losses from these arrangements.
  • Management said pending ordinary-course litigation was not expected to materially affect results, financial position or cash flows. The Visa share-sale swap may require payments if conversion terms change; management expected no further conversion-ratio payments beyond fixed quarterly charges of approximately $25,000–$50,000 until settlement finalization.
  • The company had deferred interest payments on its trust-preferred notes since February 2012, while continuing to accrue interest. Regulatory restrictions prohibit dividends without prior approval; quarterly shareholder dividends had been suspended since December 2011.

Important facts for investors to verify

  • Whether declining loan balances and pressure on the 3.49% Q3 net interest margin continue, and whether new loan production offsets repayments.
  • Progress in reducing nonperforming loans and OREO, and the adequacy of the allowance given its 60% coverage of nonperforming loans.
  • Deposit trends, the sustainability and composition of liquidity, and the implications of the nine-month deposit outflow.
  • Terms and status of deferred trust-preferred interest, regulatory dividend restrictions, and the Visa swap obligation.
  • Whether the preferred-stock investment requires further impairment and whether goodwill or other estimates change.